NEPHROPLUS

Nephrocare Health Services Ltd.

671.95-3.0 (-0.44%)
3 Jul, 3:30 PM

Income Statement

Abridged
Understanding Income Statement
Nephrocare Health Services Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PRESS
Total Revenue
437.29566.15755.81998.85
Cost of Operating Revenue
200.53235.55282.35317.46
Gross Profit
236.77330.60473.46681.39
Gross Margin
54.158.462.668.2
Total Operating Expenses
435.58517.27660.21862.55
Operating Profit
1.7248.8995.60136.30
Operating Margin
0.48.612.613.6
Financing Income/(Expense) - Net
-10.99-14.67-9.89-60.24
Profit before Taxes
-8.5933.1687.4497.47
Income Taxes
3.20-1.9720.3420.63
Profit after Tax
-11.7935.1367.1076.84
PAT Margin
-2.76.28.97.7
EPS - Basic - ex Extraordinary Items
-1.173.506.698.48
EPS - Diluted - ex Extraordinary Items
-1.173.506.698.10
EBIT
1.7248.8995.60136.30
EBITDA
48.59103.77168.07226.96
EBITDA Margin
11.118.322.222.7

Balance Sheet

Abridged
Understanding Balance Sheet
Nephrocare Health Services Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Source:
PR
PR
PR
PRESS
Total Current Assets
324390545839
Long-Term Investments
35161455
Property Plant & Equipment - Net
251305330402
Total Non-Current Assets
342416451632
Total Assets
6668069961,471
Total Current Liabilities
175243284299
Long Term Debt
9514212145
Total Non-Current Liabilities
10315012855
Total Liabilities
278392412354
Total Shareholders' Equity
3894145841,116
Total Equity
3894145841,116
Total Liabilities & Equity
6668069961,471

Cash Flow

Abridged
Understanding Cash Flow Statement
Nephrocare Health Services Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2023
Mar 31
2024
Mar 31
2025
Mar 31
2026
Mar 31
Period length:
Source:
12M
PR
12M
PR
12M
PR
12M
PRESS
Operating CF bef Changes in Working Cap
55.0396.24173.80227.73
Working Capital - Increase/(Decrease)
-53.32-33.00-44.17-5.64
Net CF from Operating Activities
1.7163.24129.62222.09
Capital Expenditures - Net
73.7480.00100.80119.14
Net CF from Investing Activities
-84.76-58.13-138.16-418.43
Stock - Issuance/(Retirement) - Net
-0.980.5697.97390.21
Debt - LT & ST - Issuance/(Retirement) - Total
77.0642.69-24.79-214.62
Net Cash Flow from Financing Activities
76.0843.2573.18175.59
Free Cash Flow to Equity
5.0325.934.04-111.67
Free Operating CF net dividend
-72.03-16.7628.83102.73
Free Operating CF
-72.03-16.7628.83102.73

Business Segment Analysis

FY End:
Mar 25

Nephrocare Health Services Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 101Cr
Healthcare services (100.0%)₹ 100.80 Cr
Revenue / Sales
Total₹ 756Cr
Healthcare services (100.0%)₹ 755.81 Cr
Assets
Total₹ 996Cr
Healthcare services (100.0%)₹ 996.46 Cr
Operating Income
Total₹ 96Cr
Healthcare services (100.0%)₹ 95.60 Cr

Regional Segment Analysis

FY End:
Mar 25

Nephrocare Health Services Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 756Cr
India (68.2%)₹ 515.50 CrPhilippines (22.0%)₹ 166.54 CrUzbekistan (9.7%)₹ 73.40 Crother (0.0%)₹ 0.37 Cr

Historical Segment Analysis

Track how Nephrocare Health Services Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2023
Mar 31
2024
Mar 31
2025
Mar 31
Healthcare services7480101

Frequently Asked Questions

What is the revenue of Nephrocare Health Services Ltd.?
The latest trailing twelve month revenue of Nephrocare Health Services Ltd. is ₹ 998.84 Cr, reflecting a 1-year growth of 32.16% and a 3-year CAGR of 31.70%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Nephrocare Health Services Ltd.?
The latest trailing twelve month net profit (PAT) of Nephrocare Health Services Ltd. is ₹ 76.84 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Nephrocare Health Services Ltd.?
The trailing twelve month EBITDA of Nephrocare Health Services Ltd. is approximately ₹ 136.30 Cr (based on an operating margin of 13.65%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Nephrocare Health Services Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Nephrocare Health Services Ltd. is 8.10. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Nephrocare Health Services Ltd.?
The debt-to-equity ratio of Nephrocare Health Services Ltd. stands at 0.07. The interest coverage ratio is 2.26x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Nephrocare Health Services Ltd.?
The estimated book value per share of Nephrocare Health Services Ltd. is 110.77 (derived from a P/B ratio of 6.07 and market price of ₹ 671.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Nephrocare Health Services Ltd.?
The trailing twelve month operating cash flow of Nephrocare Health Services Ltd. is ₹ 222.09 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Nephrocare Health Services Ltd. report consolidated or standalone financials?
Nephrocare Health Services Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.